Gilberto de Lima Lopes Selected Research

Gilberto de Lima Lopes Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 04/2007
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 12/2011
5	Breast Neoplasms (Breast Cancer) 04/2020 - 05/2011
3	Nausea 01/2015 - 05/2007
2	COVID-19 01/2022 - 10/2020
2	Vomiting 01/2015 - 05/2007
1	Esophageal Squamous Cell Carcinoma 11/2021
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Obesity 01/2020
1	Melanoma (Melanoma, Malignant) 06/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2013
1	Colonic Neoplasms (Colon Cancer) 11/2012
1	Neoplasm Metastasis (Metastasis) 11/2012
1	Colorectal Neoplasms (Colorectal Cancer) 08/2012
1	Adenocarcinoma 02/2012
1	Adenocarcinoma of Lung 02/2012
1	Exanthema (Rash) 12/2011
1	Fatigue 12/2011
1	Diarrhea 12/2011
1	Pneumonia (Pneumonitis) 12/2011
1	Hepatocellular Carcinoma (Hepatoma) 10/2011
1	Fever (Fevers) 05/2007
1	Leukocytosis (Pleocytosis) 05/2007
1	Drug-Related Side Effects and Adverse Reactions 05/2007
1	Pain (Aches) 05/2007
1	Emphysematous Cholecystitis 05/2007
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2007
1	Hyperbilirubinemia 05/2007
1	Neuroendocrine Carcinoma 04/2007
1	Acute Liver Failure (Fulminant Hepatic Failure) 04/2007

Drug/Important Bio-Agent (IBA)

4	NivolumabIBA 05/2021 - 01/2016
3	pembrolizumabIBA 05/2021 - 10/2018
3	Pharmaceutical PreparationsIBA 10/2020 - 05/2007
3	Trastuzumab (Herceptin)FDA Link 04/2020 - 05/2011
3	Biomarkers (Surrogate Marker)IBA 06/2018 - 01/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2012
3	Monoclonal AntibodiesIBA 01/2016 - 08/2012
3	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 10/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 10/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 05/2007
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2020 - 01/2020
2	Cetuximab (Erbitux)FDA Link 09/2014 - 08/2012
2	Gemcitabine FDA Link 04/2013 - 04/2007
2	Gefitinib (Iressa)FDA Link 02/2012 - 12/2011
1	SteroidsIBA 10/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2021
1	AnticoagulantsIBA 10/2021
1	camrelizumabIBA 05/2021
1	remdesivirIBA 10/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	Chimeric Antigen ReceptorsIBA 04/2018
1	osimertinibIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2016
1	LigandsIBA 01/2016
1	Bevacizumab (Avastin)FDA Link 09/2014
1	Capecitabine (Xeloda)FDA Link 09/2014
1	Panitumumab (Vectibix)FDA Link 09/2014
1	TegafurIBA 09/2014
1	Oxonic AcidIBA 09/2014
1	UracilIBA 09/2014
1	Messenger RNA (mRNA)IBA 04/2014
1	acetyltanshinone IIAIBA 04/2014
1	Fulvestrant (Faslodex)FDA Link 04/2014
1	Tamoxifen FDA LinkGeneric 04/2014
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	AcidsIBA 04/2013
1	130-nm albumin-bound paclitaxelIBA 04/2013
1	Cysteine (L-Cysteine)FDA Link 04/2013
1	eniluracilIBA 10/2011
1	Sunitinib (Sutent)FDA Link 05/2007
1	Imatinib Mesylate (Gleevec)FDA Link 05/2007
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2007
1	Carboplatin (JM8)FDA LinkGeneric 04/2007

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2011
5	Drug Therapy (Chemotherapy) 05/2021 - 04/2007
4	Immunotherapy 11/2021 - 06/2017
1	Precision Medicine 04/2018
1	Biological Therapy 09/2014
1	Palliative Care (Palliative Therapy) 11/2012
1	Cholecystostomy 05/2007